News | Health & Safety
25 May 2017 1:43
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     24 May: Auckland man smashes bungy record
     24 May: AFT Pharma confident despite losses
     23 May: Macquarie lifts F&P price target 7.3pc
     23 May: Ebos to buy Australia's HPS for $165m
     22 May: F&P Healthcare profit up 18 per cent
     20 May: Syrian war: Wounded risking retribution to receive medical care from enemy Israel
     19 May: Ryman chalks up another record profit
     Top Stories

    RUGBY RUGBY
    Wallaby, Force skipper McCalman hurt again More...


    BUSINESS BUSINESS
    Bank of PNG investigates using Blockchain to improve country's low rate of financial inclusion More...



     Today's News

    Politics:
    Australian man kidnapped in Yemen freed 21:57

    Netball:
    Steel crush Pulse for netball perfect 10 21:57

    Environment:
    Panda porn and speed dating key to species' survival 21:47

    Entertainment:
    Niall Horan and Simon Cowell "played cupid" for Liam Payne and Cheryl Tweedy 21:37

    Business:
    Bank of PNG investigates using Blockchain to improve country's low rate of financial inclusion 21:37

    Rugby League:
    Benji feels for dumped Bronco Nikorima 21:17

    Entertainment:
    Kristen Stewart's girlfriend Stella Maxwell has moved into her home 21:07

    Entertainment:
    Kanye West has reportedly retreated to Wyoming to find his "creative groove" 20:37

    Health & Safety:
    Auckland man smashes bungy record 20:27

    Entertainment:
    Zelda Williams is promoting mental health awareness 20:07


     News Search






    Power Search


    © 2017 New Zealand City Ltd